Table 2.
Select baseline characteristics of men who have sex with men (MSM) participating in a 4-month pilot study of a human immunodeficiency virus (HIV) prevention app, United States, 2015.
| Characteristic |
|
Total (n=121) | Atlanta (n=72) | Seattle (n=49) |
|
|
|
n (%) |
n (%) |
n (%) |
| Male |
|
121 (100) |
72 (100) |
49 (100) |
| Age in years, median IQRa |
|
28 (24-34) |
28 (24-35) |
28 (23-33) |
| Race or ethnicity |
|
|
|
|
|
|
White or Caucasian | 62 (51.2) |
34 (47.2) |
28 (57.1) |
|
|
Black or African American | 25 (20.7) |
24 (33.3) |
1 (2.0) |
|
|
Hispanic or Latino | 10 (8.3) |
3 (4.2) |
7 (14.3) |
|
|
Asian or Pacific Islander | 12 (9.9) |
5 (6.9) |
7 (14.3) |
|
|
Multiracial or other | 12 (9.9) |
6 (8.3) |
6(12.2) |
| Sexual orientationb |
|
|
|
|
|
|
Gay or homosexual | 104 (86.0) |
64 (88.9) |
40 (81.6) |
|
|
Bisexual | 14 (11.6) |
8 (11.1) |
6 (12.2) |
| Times tested for HIVc in last 24 months |
|
|
|
|
|
|
0 | 12 (9.9) |
8 (11.1) |
4 (8.2) |
|
|
1-2 | 50 (41.3) |
26 (36.1) |
24 (49.0) |
|
|
3-4 | 32 (26.4) |
23 (31.9) |
9 (18.4) |
|
|
5+ | 27 (22.3) |
15 (20.8) |
12 (24.5) |
| Most recent HIV test result |
|
|
|
|
|
|
Negative | 103 (85.1) |
58 (80.6) |
45 (91.8) |
|
|
Never tested or unsure | 18 (14.9) |
14 (19.4) |
4 (8.2) |
| Knows local places to get an HIV test |
|
|
|
|
|
|
Yes | 75 (62.0) |
43 (59.7) |
32 (65.3) |
|
|
No or don't know | 24 (19.8) |
14 (19.4) |
10 (20.4) |
|
|
Did not answer | 22 (18.2) |
15 (20.8) |
7 (14.3) |
| PrEPd uptake |
|
|
|
|
|
|
Never used | 106 (87.6) |
65 (90.3) |
41 (83.7) |
|
|
Previously used | 4 (3.3) |
3 (4.2) |
1 (2.0) |
|
|
Currently use | 11 (9.1) |
4 (5.6) |
7 (14.3) |
| nPEPe usage |
|
|
|
|
|
|
Ever used | 6 (5.0) |
5 (6.9) |
1 (2.0) |
| Free condoms in last 12 months |
|
|
|
|
|
|
Received and used | 55 (45.5) |
33 (45.8) |
22 (44.9) |
|
|
Received and did not use | 21 (17.4) |
12 (16.7) |
9 (18.4) |
| At-home HIV test |
|
|
|
|
|
|
Ever used | 33 (27.3) |
14 (19.4) |
19 (38.8) |
aIQR: interquartile range.
b1 missing, 1 pansexual, 1 queer for Seattle.
cHIV: human immunodeficiency virus.
dPrEP: preexposure prophylaxis.
enPEP: nonoccupational postexposure prophylaxis.